Bayer Hit with $100 Million Verdict Over Toxic PCB Exposure Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to toxic chemicals. Mic · Jan 15, 2025
Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space? Aurinia Pharmaceuticals (AUPH) released its third-quarter results, reporting solid revenue growth and robust cash flow from operations. Solid demand for its product offerings, restructuring strategies, and sound financials remain key drivers of the company’s growth and success. So, let’s analyze whether AUPH is a buy today. Read more to find… StockNews.com · Jan 14, 2025
‘Positive feedback’ from first users of Glasgow's drugs consumption room The UK’s first safer drug consumption room has had good uptake and “positive feedback” from users since opening in Glasgow, a minister has… The National (Scotland) · Jan 14, 2025
‘Positive feedback’ from first users of safer drugs consumption room – minister Neil Gray said the success of the Thistle Centre would be measured if there are fewer drug deaths and ‘harm reduction’. Evening Standard · Jan 14, 2025
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies The Independent UK · Jan 13, 2025
GSK to buy US cancer drug firm IDRx for up to $1.15bn Massachusetts-based company is working on new treatments for gastrointestinal cancers The Guardian - UK · Jan 13, 2025
Scotland's first safe drug consumption room has opened – here's how it works SCOTLAND’S first safe drug consumption room has officially opened its doors in Glasgow on Monday ... The National (Scotland) · Jan 13, 2025
From the Beatles to biologics – how Liverpool became a life science hotspot The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe The Guardian - UK · Jan 12, 2025
Ex-McKinsey partner pleads guilty to destroying records on opioids Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales The Guardian - US · Jan 10, 2025
Swinney: Consumption room should help reduce ‘entirely unacceptable’ drug deaths The First Minister has visited the UK’s first facility where drug users can inject in a clean and safe environment. Evening Standard · Jan 10, 2025
USTR warns of risks from online pharmacies in its 'notorious markets' report An annual U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says that nearly all 35,000 online pharmacies around the world are being run illegally The Independent UK · Jan 9, 2025
3 Blue-Chip Stocks with Strong Buy Ratings from Analysts As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from… StockNews.com · Jan 8, 2025
Moderna Stock Is Volatile Amid Bird Flu Developments Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know. Kiplinger · Jan 8, 2025
Wegovy maker Novo Nordisk sponsored British pharmacies in pursuit of sales Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions The Guardian - UK · Jan 4, 2025
StockNews.com · Dec 24, 2024 3 Specialty Pharma Stocks Addressing Unmet Medical Needs The specialty pharma sector is leading the charge in developing life-changing solutions for rare and chronic conditions. Amid this backdrop, investors might consider adding three fundamentally solid specialty pharma stocks, namely, Ipsen S.A. (IPSEY), ACADIA Pharmaceuticals (ACAD), and Neurocrine Biosciences (NBIX) in their portfolios. Read on….
Latin Times · Dec 24, 2024 Judge in Luigi Mangione Case Married to Ex-Pfizer Executive, Owns Thousands in Healthcare Stock: Report The judge presiding over pre-trial hearings for Luigi Mangione has come under scrutiny for her financial and familial ties to the healthcare industry.
Tom’s Hardware · Dec 19, 2024 AMD's 'Golden Rabbit' GPU reportedly hits 'end of life' status — Radeon RX 7900 GRE is no longer available at any retailer Tweakers reports that several AMD add-in board partners confirmed the upper mid-range RX 7900 GRE is now declared "end-of-life" and is no longer being produced.
The Independent UK · Dec 19, 2024 DOJ files complaint against CVS for facilitating unlawful sale of prescription opioids The Justice Department has unsealed a civil complaint alleging CVS Pharmacy Inc. and various subsidiaries filled unlawful prescriptions in violation of the federal Controlled Substances Act
StockNews.com · Dec 18, 2024 3 High-Yield Dividend Stocks to Secure Before Year-End Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time. Therefore, investors might consider adding dividend stocks, Pfizer (PFE), United Parcel Service (UPS), and Enterprise Products Partners (EPD) before year-end. Read more….
StockNews.com · Dec 17, 2024 Is Exelixis Positioned to Capitalize on Emerging Cancer Therapies? In the expanding oncology market, Exelixis (EXEL) is gaining attention with its strong pipeline and impressive stock performance. With a clear focus on cancer treatment innovation and a growing market presence, is the company set to lead the future of cancer care and treatment? Read more….
The Guardian - US · Dec 14, 2024 UnitedHealth chief admits US health system ‘does not work as well as it should’ In a New York Times essay, Andrew Witty also says slain healthcare CEO Brian Thompson cared about customers
The Guardian - US · Dec 13, 2024 McKinsey to pay $650m to resolve US investigation into opioid crisis role Consultancy giant agrees to two criminal counts, including for conspiring with drug manufacturers, in DoJ settlement
Top News · Dec 13, 2024 Mckinsey To Pay 0 Million In Purdue Pharma Settlement McKinsey & Company agrees to pay 0 million in settlement for its role in Purdue Pharma's opioid crisis, impacting addiction and overdose prevention efforts.
The Independent UK · Dec 13, 2024 McKinsey & Company agrees to pay $650 million to settle federal probe over opioids work McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia
StockNews.com · Dec 12, 2024 3 Healthcare Innovators Revolutionizing Patient Care The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D efforts. Thus, investors could consider quality healthcare innovator stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and Bristol-Myers Squibb (BMY) as portfolio additions for potential gains. Continue reading.